Limoneira (LMNR) Competitors

Limoneira (NASDAQ:LMNR) and Alico (NASDAQ:ALCO) are both small-cap consumer staples companies, but which is the superior stock? We will compare the two companies based on the strength of their profitability, valuation, dividends, earnings, institutional ownership, analyst recommendations, media sentiment, risk and community ranking.

Which has stronger earnings & valuation, LMNR or ALCO?

Limoneira has higher revenue and earnings than Alico. Limoneira is trading at a lower price-to-earnings ratio than Alico, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Limoneira	$176.59M	1.60	$7.72M	-$0.14	-112.07
Alico	$49.42M	4.83	$6.97M	-$18.43	-1.69

Is LMNR or ALCO more profitable?

Limoneira has a net margin of 4.03% compared to Alico's net margin of -91.09%. Limoneira's return on equity of 4.34% beat Alico's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Limoneira	4.03%	4.34%	2.68%
Alico	-91.09%	-3.01%	-1.95%

Does the MarketBeat Community favor LMNR or ALCO?

Limoneira received 106 more outperform votes than Alico when rated by MarketBeat users. Likewise, 61.47% of users gave Limoneira an outperform vote while only 61.39% of users gave Alico an outperform vote.

Company	Underperform	Outperform
Limoneira	Outperform Votes 292 61.47%	Underperform Votes 183 38.53%
Alico	Outperform Votes 186 61.39%	Underperform Votes 117 38.61%

Do analysts rate LMNR or ALCO?

Limoneira presently has a consensus price target of $25.50, suggesting a potential upside of 62.52%. Given Limoneira's stronger consensus rating and higher possible upside, equities research analysts plainly believe Limoneira is more favorable than Alico.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Limoneira	0 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	3.00
Alico	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

Do institutionals and insiders hold more shares of LMNR or ALCO?

64.3% of Limoneira shares are held by institutional investors. Comparatively, 62.3% of Alico shares are held by institutional investors. 8.9% of Limoneira shares are held by company insiders. Comparatively, 8.3% of Alico shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Does the media favor LMNR or ALCO?

In the previous week, Limoneira had 17 more articles in the media than Alico. MarketBeat recorded 20 mentions for Limoneira and 3 mentions for Alico. Alico's average media sentiment score of 0.63 beat Limoneira's score of 0.17 indicating that Alico is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Limoneira	4 Very Positive mention(s)	1 Positive mention(s)	9 Neutral mention(s)	3 Negative mention(s)	0 Very Negative mention(s)	Neutral
Alico	1 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Is LMNR or ALCO a better dividend stock?

Limoneira pays an annual dividend of $0.30 per share and has a dividend yield of 1.9%. Alico pays an annual dividend of $0.20 per share and has a dividend yield of 0.6%. Limoneira pays out -214.3% of its earnings in the form of a dividend. Alico pays out -1.1% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Limoneira is clearly the better dividend stock, given its higher yield and lower payout ratio.

Which has more risk and volatility, LMNR or ALCO?

Limoneira has a beta of 0.45, suggesting that its stock price is 55% less volatile than the S&P 500. Comparatively, Alico has a beta of 0.99, suggesting that its stock price is 1% less volatile than the S&P 500.

Summary

Limoneira beats Alico on 17 of the 20 factors compared between the two stocks.